Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Evolent Health, Inc. stock logo
EVH
Evolent Health
$9.98
-1.0%
$9.79
$8.35
$33.63
$1.16B1.492.24 million shs2.97 million shs
Flywire Co. stock logo
FLYW
Flywire
$9.10
-2.0%
$14.24
$8.62
$23.90
$1.12B1.221.62 million shs3.17 million shs
Ibotta, Inc. stock logo
IBTA
Ibotta
$44.19
-0.1%
$54.26
$31.40
$117.59
$1.23BN/A452,356 shs437,964 shs
OmniAb, Inc. stock logo
OABI
OmniAb
$2.09
-6.3%
$3.17
$2.01
$5.45
$255.26M-0.14551,181 shs639,942 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Evolent Health, Inc. stock logo
EVH
Evolent Health
-1.74%+4.02%+13.99%-15.99%-66.88%
Flywire Co. stock logo
FLYW
Flywire
-2.05%-5.21%-15.27%-55.50%-62.08%
Ibotta, Inc. stock logo
IBTA
Ibotta
+0.18%+3.98%+26.26%-34.66%+4,418,999,900.00%
OmniAb, Inc. stock logo
OABI
OmniAb
-6.28%-13.64%-38.71%-43.21%-61.15%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Evolent Health, Inc. stock logo
EVH
Evolent Health
2.4768 of 5 stars
4.52.00.00.02.01.70.0
Flywire Co. stock logo
FLYW
Flywire
3.7598 of 5 stars
4.23.00.00.01.83.31.9
Ibotta, Inc. stock logo
IBTA
Ibotta
N/AN/AN/AN/AN/AN/AN/AN/A
OmniAb, Inc. stock logo
OABI
OmniAb
2.7499 of 5 stars
3.52.00.00.01.93.31.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Evolent Health, Inc. stock logo
EVH
Evolent Health
3.00
Buy$17.7177.50% Upside
Flywire Co. stock logo
FLYW
Flywire
2.33
Hold$17.9296.96% Upside
Ibotta, Inc. stock logo
IBTA
Ibotta
0.00
N/AN/AN/A
OmniAb, Inc. stock logo
OABI
OmniAb
3.00
Buy$7.00234.93% Upside

Current Analyst Ratings Breakdown

Latest OABI, FLYW, IBTA, and EVH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/2/2025
Flywire Co. stock logo
FLYW
Flywire
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$15.00 ➝ $11.00
3/27/2025
OmniAb, Inc. stock logo
OABI
OmniAb
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$7.00 ➝ $4.00
3/24/2025
Flywire Co. stock logo
FLYW
Flywire
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$26.00 ➝ $13.00
3/20/2025
OmniAb, Inc. stock logo
OABI
OmniAb
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$8.00 ➝ $6.00
3/19/2025
OmniAb, Inc. stock logo
OABI
OmniAb
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00 ➝ $11.00
3/10/2025
Evolent Health, Inc. stock logo
EVH
Evolent Health
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$13.00 ➝ $12.00
2/26/2025
Flywire Co. stock logo
FLYW
Flywire
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$25.00 ➝ $20.00
2/26/2025
Flywire Co. stock logo
FLYW
Flywire
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$21.00 ➝ $15.00
2/26/2025
Flywire Co. stock logo
FLYW
Flywire
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$20.00 ➝ $16.00
2/26/2025
Flywire Co. stock logo
FLYW
Flywire
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$25.00 ➝ $15.00
2/26/2025
Flywire Co. stock logo
FLYW
Flywire
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$26.00 ➝ $16.00
(Data available from 4/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Evolent Health, Inc. stock logo
EVH
Evolent Health
$2.55B0.46$1.66 per share6.00$9.38 per share1.06
Flywire Co. stock logo
FLYW
Flywire
$492.14M2.29$0.04 per share255.58$6.41 per share1.42
Ibotta, Inc. stock logo
IBTA
Ibotta
$367.25M3.36N/AN/AN/A
OmniAb, Inc. stock logo
OABI
OmniAb
$26.39M9.67N/AN/A$2.69 per share0.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Evolent Health, Inc. stock logo
EVH
Evolent Health
-$113.04M-$0.82N/AN/AN/A-2.41%5.73%2.36%5/8/2025 (Estimated)
Flywire Co. stock logo
FLYW
Flywire
-$8.57M$0.0260.6736.401.414.23%2.49%1.86%5/6/2025 (Estimated)
Ibotta, Inc. stock logo
IBTA
Ibotta
N/A$1.7924.69N/AN/AN/AN/AN/A
OmniAb, Inc. stock logo
OABI
OmniAb
-$50.62M-$0.60N/AN/AN/A-308.78%-20.97%-18.05%5/8/2025 (Estimated)

Latest OABI, FLYW, IBTA, and EVH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2025Q4 2024
OmniAb, Inc. stock logo
OABI
OmniAb
-$0.13-$0.12+$0.01-$0.12$10.13 million$10.80 million
2/25/2025Q4 2024
Flywire Co. stock logo
FLYW
Flywire
-$0.01-$0.12-$0.11-$0.12$118.85 million$112.80 million
2/20/2025Q4 2024
Evolent Health, Inc. stock logo
EVH
Evolent Health
$0.38$0.03-$0.35-$0.27$650.92 million$646.54 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Evolent Health, Inc. stock logo
EVH
Evolent Health
N/AN/AN/AN/AN/A
Flywire Co. stock logo
FLYW
Flywire
N/AN/AN/AN/AN/A
Ibotta, Inc. stock logo
IBTA
Ibotta
$0.020.05%N/A1.12%N/A
OmniAb, Inc. stock logo
OABI
OmniAb
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Evolent Health, Inc. stock logo
EVH
Evolent Health
0.58
1.04
1.04
Flywire Co. stock logo
FLYW
Flywire
N/A
2.33
2.33
Ibotta, Inc. stock logo
IBTA
Ibotta
N/AN/AN/A
OmniAb, Inc. stock logo
OABI
OmniAb
N/A
4.62
4.62

Institutional Ownership

CompanyInstitutional Ownership
Evolent Health, Inc. stock logo
EVH
Evolent Health
N/A
Flywire Co. stock logo
FLYW
Flywire
95.90%
Ibotta, Inc. stock logo
IBTA
Ibotta
N/A
OmniAb, Inc. stock logo
OABI
OmniAb
72.08%

Insider Ownership

CompanyInsider Ownership
Evolent Health, Inc. stock logo
EVH
Evolent Health
1.60%
Flywire Co. stock logo
FLYW
Flywire
3.90%
Ibotta, Inc. stock logo
IBTA
Ibotta
N/A
OmniAb, Inc. stock logo
OABI
OmniAb
8.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Evolent Health, Inc. stock logo
EVH
Evolent Health
5,100116.59 million114.70 millionOptionable
Flywire Co. stock logo
FLYW
Flywire
660123.59 million119.57 millionOptionable
Ibotta, Inc. stock logo
IBTA
Ibotta
N/A27.89 millionN/AN/A
OmniAb, Inc. stock logo
OABI
OmniAb
7122.14 million129.07 millionOptionable

Recent News About These Companies

OmniAb price target lowered to $4 from $7 at RBC Capital
OmniAb price target lowered to $6 from $8 at Benchmark
OmniAb, Inc. stock logo
OmniAb (NASDAQ:OABI) Releases Earnings Results
OmniAb reports Q4 EPS (12c), consensus (10c)
OmniAb shares surge as Q4 revenue more than doubles

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Evolent Health stock logo

Evolent Health NYSE:EVH

$9.98 -0.10 (-0.99%)
Closing price 04/4/2025 03:59 PM Eastern
Extended Trading
$9.65 -0.33 (-3.31%)
As of 04/4/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Flywire stock logo

Flywire NASDAQ:FLYW

$9.10 -0.19 (-2.05%)
Closing price 04/4/2025 04:00 PM Eastern
Extended Trading
$9.10 +0.01 (+0.05%)
As of 04/4/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Flywire Corporation, together with its subsidiaries, operates as a payments enablement and software company in the United States and internationally. Its payment platform and network, and vertical-specific software help clients to get paid and help their customers to pay. The company's platform facilitates payment flows across multiple currencies, payment types, and payment options, as well as provides direct connections to alternative payment methods, such as Alipay, Boleto, PayPal/Venmo, and Trustly. It serves education, healthcare, travel, and business to business organizations. The company was formerly known as peerTransfer Corporation and changed its name to Flywire Corporation in December 2016. Flywire Corporation was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Ibotta stock logo

Ibotta NYSE:IBTA

$44.19 -0.03 (-0.07%)
As of 04/4/2025 03:58 PM Eastern

Ibotta’s mission is to Make Every Purchase Rewarding. Our technology allows CPG brands to deliver digital promotions to over 200 million consumers through a single, convenient network called the Ibotta Performance Network (IPN). We are pioneers in success-based marketing: we only get paid when our client’s promotion results in a sale, not when a consumer merely views or clicks on the promotion. We have built the largest digital item-level promotions network in the United States by forming strategic relationships with major retailers such as Walmart Inc. (Walmart) and Dollar General Corporation (Dollar General), which use our digital offers to power their loyalty programs on a white-label basis. Through the IPN, our clients can also reach millions more consumers on our widely used rewards app digital properties, which include the Ibotta-branded cash back mobile app, website, and browser extension (collectively, Ibotta D2C). We work directly with over 850 different clients, representing over 2,400 different CPG brands to source exclusive offers as of December 31, 2023. Most of our offers cover products in non-discretionary categories, such as grocery, but we also work with general merchandise manufacturers in categories such as toys, clothing, beauty, electronics, pet, home goods, and sporting goods. Over time, our clients have generally ramped up their spend with us, and they rarely drop off our network. In fact, of our top 100 clients, 96% were retained from 2022 to 2023. Our technology platform uses an Artificial Intelligence (AI)-enabled offer engine that is designed to match and distribute the right offer to the right consumer at the right time. This is possible because we receive a large volume of item-level purchase data through our secure point of sale (POS) integrations with 85 different retailers as of December 31, 2023. Using this data, we form a profile of each consumer based on what they have bought in the past and how they have responded to various price promotions. From there, we build recommenders that are driven by machine learning and designed to create personalized savings experiences for each consumer. The more data we accumulate, the smarter our recommenders become. Whatever our clients’ specific objectives may be – such as encouraging brand switching, shortening purchase cycles, incentivizing consumers to stock up, or promoting around key seasonal events – our platform helps them design a promotional campaign to accomplish their goals. Ibotta’s technology tracks which offers are selected by consumers, matches offers to the products that have been purchased, logs redemptions, handles the flow of funds, and takes care of all downstream billing and logistics. We perform the function of “air traffic control,” meaning our network enables offers to be matched, distributed, and redeemed across multiple large third-party publishers in a coordinated fashion. This minimizes the risks that offer budgets are exceeded and that consumers redeem the same offer several times for a single purchase (i.e., offer stacking). Our client tools allow CPG brands to set up campaigns, monitor redemption and budget levels, and analyze overall campaign performance – all in a single, convenient interface. We deliver success-based digital promotions at-scale because we manage a growing, open network of third-party publishers that host our offers. Retailers are among our most important publishers because their apps and websites are frequently visited by consumers with high purchase intent. A retailer may ingest digital offers from Ibotta’s Application Programming Interface (API) and present them to its consumers as part of its own branded loyalty program. We call these partners “retailer publishers.” We believe retailer publishers choose to work with Ibotta because we are a trusted partner that can provide a large universe of exclusive offers coupled with a set of plug and play capabilities that would be difficult for them to create and scale on their own. For example, Ibotta and Walmart entered into a multi-year strategic relationship that makes Ibotta the exclusive provider of digital item-level rebate offer content for Walmart U.S., across all product categories, for online and offline shopping. Consumers redeem our offers on Walmart properties without ever creating an Ibotta account. Instead, they can select manufacturer offers from the Walmart website or app, buy the featured items in-store or online, and instantly earn Walmart Cash which can be applied to future purchases in a Walmart store or on Walmart.com. All CPG brands wishing to run digital item-level rebates on Walmart’s website can only do so through the IPN. Ibotta also partners with several other leading retailer publishers. For example, Ibotta partners with Family Dollar, a subsidiary of Dollar Tree, Inc. We also work indirectly to publish offers on certain retailer properties, including Kroger (powering Kroger Cash) and Shell (powering Shell Fuel Rewards). In addition to providing digital offers for retailers, Ibotta also makes the same offers available on its own digital properties, which include Ibotta D2C. Since 2012, over 50 million Americans have registered for our free app. Ibotta D2C reaches a highly engaged audience of savings-conscious consumers who want a single digital starting point where they can find cash back offers across a variety of retailers. Many of these consumers decide where to shop based on the availability of deals in different retailers. Once the IPN launched, Ibotta D2C became a publisher on the IPN, meaning it is now one of many nodes through which our digital offers are delivered to the end consumer. In the future, we believe the IPN may be extended to other publishers across a variety of new verticals. For example, new publishers could include delivery services, banks, or other apps and websites that want to give their consumers access to offers on popular everyday items without having to source those offers from thousands of different CPG brands or secure item-level data from multiple integrated retailers where the offers can be redeemed. We believe Ibotta is well positioned to capitalize on a large and growing market opportunity. U.S. consumers spent approximately $1.2 trillion dollars in the grocery sector in 2023. CPG brands compete fiercely to influence consumer spending habits, spending approximately $200 billion on marketing annually in the United States. In fact, no other industry spends more on marketing, as a percentage of overall budgets, than CPG. Most of our revenue is redemption revenue which is generated from redemptions of offers across the IPN. A significant portion of that redemption revenue arises from offer redemptions on third-party publishers. We also generate revenue by selling ad products on our Ibotta D2C properties. Specifically, we allow CPG brands and retailers to enhance awareness of their offers by buying display ads, in-app videos, or email marketing campaigns. We also charge partners a licensing fee to leverage our aggregated data in ways that help them better understand their target consumers and improve their promotional activities. Finally, on Ibotta’s D2C properties, we also allow thousands of online retailers to advertise and present consumers with their own sitewide cash back offers. These clients benefit from the incremental sales generated by Ibotta’s savings-conscious audience. Our revenue growth significantly accelerated with the addition of new publishers to the IPN. Most recently, the rollout of our offers on the digital property of Walmart has attracted larger audiences, and in turn, resulted in greater spend by CPG brands and a greater number of redeemed offers. These developments have increased our scale, growth and profitability. • Total revenue grew from $210.7 million in 2022 to $320.0 million in 2023, an increase of 52%; • Redemption revenue grew from $138.7 million (or 66% of total revenue) in 2022 to $243.9 million (or 76% of total revenue) in 2023, an increase of 76%; • Gross profit grew from $164.5 million in 2022 to $276.0 million in 2023, an increase of 68%; • Net income (loss) improved from $(54.9) million in 2022 to $38.1 million in 2023; • Net income (loss) as a percent of revenue improved from (26)% in 2022 to 12% in 2023; and • Adjusted EBITDA margin improved from (13)% in 2022 to 26% in 2023. We were incorporated in 2011 as Zing Enterprises, Inc., a Delaware corporation. In 2012, we changed our name to Ibotta, Inc. Our principal executive office is located at 1801 California Street, Suite 400, Denver, Colorado.

OmniAb stock logo

OmniAb NASDAQ:OABI

$2.09 -0.14 (-6.28%)
Closing price 04/4/2025 04:00 PM Eastern
Extended Trading
$2.06 -0.03 (-1.44%)
As of 04/4/2025 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.